Direct Use of Non-centrifuged Autologous Fat Graft
Direct Use of Autologous Fat Graft on The Treatment of Lower Extremity Wounds
1 other identifier
observational
16
0 countries
N/A
Brief Summary
There are a limited number of reports related to the direct use of non-centrifuged adipose tissue graft in the literature. This preliminary study aims to present our experience on the efficacy of autologous fat graft use without centrifuging in the treatment of lower extremity wounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2020
CompletedFirst Submitted
Initial submission to the registry
May 6, 2021
CompletedFirst Posted
Study publicly available on registry
May 21, 2021
CompletedMay 21, 2021
May 1, 2021
3.2 years
May 6, 2021
May 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wounds examination
Collection of the data from clinical observation and photograph records were made to follow the wounds. the observations were made during changing the wound dressing and generally every three days.
6 months
Secondary Outcomes (2)
Wounds classification according to data from files and photographs
3 months
Final evaluation and data achieving from files and exam carts
3 months
Interventions
Autologous fat grafts were harvested from abdominal or gluteal regions of the patients and injected into the wound bed and wound environment. Clinical observation and photograph records were used to follow the wounds.
Eligibility Criteria
16 lower extremity wounds were included in the study between January 2016-October 2019 years. All patients were treated by two surgeons in the same clinic. The wounds were those that continued for at least three months of high to moderate exudate and required open management of the secondary intervention. The etiologies of the wounds were diabetic, venous or traumatic ulcers.
You may qualify if:
- diabetic,
- venous
- traumatic wounds
You may not qualify if:
- Malignancy,
- A life expectation \<1 year,
- Chemical or radiation exposure.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Goncalves AI, Gershovich PM, Rodrigues MT, Reis RL, Gomes ME. Human adipose tissue-derived tenomodulin positive subpopulation of stem cells: A promising source of tendon progenitor cells. J Tissue Eng Regen Med. 2018 Mar;12(3):762-774. doi: 10.1002/term.2495. Epub 2017 Oct 4.
PMID: 28593712BACKGROUNDHivernaud V, Lefourn B, Robard M, Guicheux J, Weiss P. Autologous fat grafting: A comparative study of four current commercial protocols. J Plast Reconstr Aesthet Surg. 2017 Feb;70(2):248-256. doi: 10.1016/j.bjps.2016.11.022. Epub 2016 Dec 14.
PMID: 28043786BACKGROUNDConde-Green A, Marano AA, Lee ES, Reisler T, Price LA, Milner SM, Granick MS. Fat Grafting and Adipose-Derived Regenerative Cells in Burn Wound Healing and Scarring: A Systematic Review of the Literature. Plast Reconstr Surg. 2016 Jan;137(1):302-312. doi: 10.1097/PRS.0000000000001918.
PMID: 26710034BACKGROUNDTuncel U, Kostakoglu N, Turan A, Cevik B, Cayli S, Demir O, Elmas C. The Effect of Autologous Fat Graft with Different Surgical Repair Methods on Nerve Regeneration in a Rat Sciatic Nerve Defect Model. Plast Reconstr Surg. 2015 Dec;136(6):1181-1191. doi: 10.1097/PRS.0000000000001822.
PMID: 26273733BACKGROUNDMoyer HR, Namnoum JD. Autologous Fat Transfer: The Progenitor Cell Response to Different Recipient Environments. Aesthet Surg J. 2014 Aug;34(6):932-40. doi: 10.1177/1090820X14536903. Epub 2014 Aug 1.
PMID: 24936093BACKGROUNDHyldig K, Riis S, Pennisi CP, Zachar V, Fink T. Implications of Extracellular Matrix Production by Adipose Tissue-Derived Stem Cells for Development of Wound Healing Therapies. Int J Mol Sci. 2017 May 31;18(6):1167. doi: 10.3390/ijms18061167.
PMID: 28561757BACKGROUNDvan de Vyver M. Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell Therapy. Stem Cells Dev. 2017 Jul 15;26(14):1042-1053. doi: 10.1089/scd.2017.0025. Epub 2017 May 18.
PMID: 28447876BACKGROUNDHur W, Lee HY, Min HS, Wufuer M, Lee CW, Hur JA, Kim SH, Kim BK, Choi TH. Regeneration of full-thickness skin defects by differentiated adipose-derived stem cells into fibroblast-like cells by fibroblast-conditioned medium. Stem Cell Res Ther. 2017 Apr 20;8(1):92. doi: 10.1186/s13287-017-0520-7.
PMID: 28427476BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Umut Tuncel, Assoc Prof
Samsun Liv Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2021
First Posted
May 21, 2021
Study Start
March 2, 2016
Primary Completion
May 13, 2019
Study Completion
March 18, 2020
Last Updated
May 21, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share